Literature DB >> 15312049

Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.

Michael R Webb1, Susan E Ebeler.   

Abstract

Flavonoids and other polyphenolic compounds have been shown to inhibit human topoisomerase IB (topo I) through both inhibition of relaxation activity and through stabilization of the cleavable complex (poisoning). Some flavonoids have also been shown to intercalate DNA, and an association of topoisomerase inhibition with intercalation has been noted. We surveyed 34 polyphenolic compounds, primarily flavonoid glycones and aglycones, for their ability to inhibit topo I and to intercalate DNA using an in vitro gel electrophoresis method. We show that the most potent topo I poisons are the flavones and flavonols, and that these generally, but not always, are found to be DNA intercalators. There was no clear correlation, however, of topo-I-poisoning activity with the degree of DNA unwinding. Surprisingly, both DNA intercalation and topo I poisoning were shown to occur with some flavone glycones, including the C-glycosylflavone orientin. Inhibition of relaxation activity by flavonoids was found to be difficult to quantify and was most likely to be due to non-specific inhibition through flavonoid aggregation. As part of a structure-activity analysis, we also investigated the acid-base chemistry of flavonoids and determined that many flavonoids show acid-base activity with a pK(a) in the physiological pH region. For this reason, subtle pH changes can have significant effects on solution activity of flavonoids and their concomitant biological activity. In addition, these effects may be complicated by pH-dependent aggregation and oxidative degradation. Finally, we develop a simple model for the intercalation of flavonoids into DNA and discuss possible consequences of intercalation and topoisomerase inhibition on a number of cellular processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312049      PMCID: PMC1134138          DOI: 10.1042/BJ20040474

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  RecQ helicase and topoisomerase III comprise a novel DNA strand passage function: a conserved mechanism for control of DNA recombination.

Authors:  F G Harmon; R J DiGate; S C Kowalczykowski
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

2.  Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents.

Authors:  I D Silva; J Gaspar; G G da Costa; A S Rodrigues; A Laires; J Rueff
Journal:  Chem Biol Interact       Date:  2000-01-03       Impact factor: 5.192

3.  Structural aspects of antioxidant activity of flavonoids.

Authors:  S A van Acker; D J van den Berg; M N Tromp; D H Griffioen; W P van Bennekom; W J van der Vijgh; A Bast
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

4.  Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs.

Authors:  D S Pilch; C Yu; D Makhey; E J LaVoie; A R Srinivasan; W K Olson; R R Sauers; K J Breslauer; N E Geacintov; L F Liu
Journal:  Biochemistry       Date:  1997-10-14       Impact factor: 3.162

5.  Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.

Authors:  A Constantinou; R Mehta; C Runyan; K Rao; A Vaughan; R Moon
Journal:  J Nat Prod       Date:  1995-02       Impact factor: 4.050

6.  Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.

Authors:  C Bailly; L Dassonneville; P Colson; C Houssier; K Fukasawa; S Nishimura; T Yoshinari
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

7.  Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines.

Authors:  S Kuntz; U Wenzel; H Daniel
Journal:  Eur J Nutr       Date:  1999-06       Impact factor: 5.614

8.  Can the concept of hormesis Be generalized to carcinogenesis?

Authors:  E J Calabrese; L A Baldwin
Journal:  Regul Toxicol Pharmacol       Date:  1998-12       Impact factor: 3.271

9.  Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I.

Authors:  F Boege; T Straub; A Kehr; C Boesenberg; K Christiansen; A Andersen; F Jakob; J Köhrle
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives.

Authors:  C A Austin; S Patel; K Ono; H Nakane; L M Fisher
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

View more
  18 in total

1.  MAX1, a regulator of the flavonoid pathway, controls vegetative axillary bud outgrowth in Arabidopsis.

Authors:  Gabor Lazar; Howard M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

2.  Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan.

Authors:  Nada Oršolić; Vesna Benković; Duje Lisičić; Domagoj Dikić; Julija Erhardt; Anica Horvat Knežević
Journal:  Med Oncol       Date:  2009-12-16       Impact factor: 3.064

Review 3.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

4.  Anthocyanin Interactions with DNA: Intercalation, Topoisomerase I Inhibition and Oxidative Reactions.

Authors:  Michael R Webb; Kyungmi Min; Susan E Ebeler
Journal:  J Food Biochem       Date:  2008-09-23       Impact factor: 2.720

5.  Evaluation of flavonoids binding to DNA duplexes by electrospray ionization mass spectrometry.

Authors:  Zhaofu Wang; Meng Cui; Fengrui Song; Lin Lu; Zhiqiang Liu; Shuying Liu
Journal:  J Am Soc Mass Spectrom       Date:  2008-04-10       Impact factor: 3.109

6.  Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.

Authors:  Malgorzata N Drwal; Keli Agama; Laurence P G Wakelin; Yves Pommier; Renate Griffith
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.

Authors:  Benu Brata Das; Nilkantha Sen; Amit Roy; Somdeb Bose Dasgupta; Agneyo Ganguly; Bikash Chandra Mohanta; Biswanath Dinda; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2006-02-18       Impact factor: 16.971

8.  Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells.

Authors:  Zhuhong Zhang; Si Chen; Hu Mei; Jiekun Xuan; Xiaoqing Guo; Letha Couch; Vasily N Dobrovolsky; Lei Guo; Nan Mei
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

9.  Theoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparum.

Authors:  Wilian A Cortopassi; Julia Penna-Coutinho; Anna C C Aguiar; André S Pimentel; Camilla D Buarque; Paulo R R Costa; Bruna R M Alves; Tanos C C França; Antoniana U Krettli
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  Gold(III) macrocycles: nucleotide-specific unconventional catalytic inhibitors of human topoisomerase I.

Authors:  Kate J Akerman; Alexander M Fagenson; Vidusha Cyril; Michael Taylor; Mark T Muller; Matthew P Akerman; Orde Q Munro
Journal:  J Am Chem Soc       Date:  2014-04-02       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.